Monthly Archives: August 2019

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In GTT Communications, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in GTT Communications, Inc. (“GTT” or the “Company”) (NYSE:GTT) of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in GTT stock or options between February 26, 2018 and July 1, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/GTT. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Eastern District of Virginia on behalf of all those who purchased GTT securities between February 26, 2018 and July 1, 2019 (the “Class Period”). The case, Plymouth County Retirement System v. GTT Communications, Inc., No. 1:19-cv-00982 was filed on July 30, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by issuing a series of false and/or misleading statements and failing to disclose material adverse facts about GTT’s business, operations, and prospects, and the Interoute acquisition specifically. Among other things, Defendants failed to disclose that: (1) there were delays in migrating Interoute’s legacy systems and processes into GTT’s client management database system; (2) Interoute had made a strategic shift to focus on providing cloud services that deviated from GTT’s core cloud networking business; (3) Interoute’s sales force was underperforming and ineffective at selling GTT’s core cloud networking services; and (4) as a result of the foregoing,

Defendants’ public statements were materially false and/or misleading and/or lacked a reasonable basis.

Specifically, on May 8, 2019 GTT disclosed a larger than expected loss for the first quarter of 2019, including a sequential decline in revenues. GTT blamed its poor performance on a host of issues with the Interoute integration, including migrating legacy systems into GTT’s management database, discrepancies with Interoute’s billing systems, and a poor salesforce. GTT further disclosed that shortly before the acquisition, Interoute had made a strategic shift to sell cloud services that deviated from GTT’s core cloud networking business. In response to these disclosures, GTT’s stock price plummeted 17.5% on May 8, 2019, and continued to fall the following day, for a two-day decline of over 25%.

On this news, GTT’s stock price fell from $40.29 on May 7, 2019 to $33.25 on May 8, 2019-a $7.04 or a 17.47% drop. The stock price continued to fall the following day, closing at only $29.91 per share, for a two-day decline of over 25%.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding GTT’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 557598

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Just Energy Group Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Just Energy Group Inc. (“Just Energy” or the “Company”)(NYSE:JE) of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Just Energy stock or options between November 9, 2017 and July 23, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/JE. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Just Energy securities between November 9, 2017 and July 23, 2019 (the “Class Period”). The case, Goitein v. Just Energy Group Inc. et al., No. 19-cv-07181 was filed on July 31, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that the Company experienced customer enrollment and nonpayment issues and that, as a result, the Company was reasonably likely to incur an impairment charge to its accounts receivable.

On July 23, 2019, the Company disclosed that it had “identified customer enrollment [sic] and non-payment issues, primarily in Texas, over the past 12 months” and that, as a result, it expected an impairment charge of CAD $45 to $50 million to its Texas residential accounts receivable.

On this news, Just Energy’s share price fell from $4.38 per share on July 22, 2019 to a closing price of $3.72 on July 23, 2019: a $0.66 or a 15.10% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Just Energy’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 557597

Atlas Mara Limited Announces Buyback of Shares 28/08/2019

Atlas Mara Repurchase of Shares and Total Voting Rights Update

TORTOLA / ACCESSWIRE / August 28, 2019 / Atlas Mara Limited (LSE:ATMA) (“Atlas Mara” or the “Company” and, including its subsidiaries, the “Group”), the sub-Sahara African financial services group, today announces that on 27 August 2019, the Company repurchased 7,000 shares, all of which were purchased at an average price of $1.20 and will be held as treasury shares.

Atlas Mara repurchased shares pursuant to the authority granted by its Board of Directors, announced in its Q3 2018 Results RNS, to reinstate a lapsed share purchase program. The granted authority is for Atlas Mara to repurchase the Company’s issued share capital up to an aggregate market value equivalent to $10 million by way of its nominated brokers.

As a result of the repurchase of shares, Atlas Mara’s total number of ordinary shares in issue is 174,618,767 of which 1,548,062 are now held in treasury with an additional 3,298,298 ordinary shares held in escrow as part of the contingent consideration for the acquisition of FBZ. Atlas Mara hereby notifies the market that the total number of voting rights in Atlas Mara is 169,772,407. In accordance with rule 5.6.1 of the Financial Conduct Authority’s Disclosure and Transparency Rules (“DTRs”), this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Atlas Mara under the DTRs.

Contact Details
Investors

Kojo Dufu, +1 212 883 4330

Media

Anthony Silverman, +44 (0)7818 036 579

About Atlas Mara

Atlas Mara Limited (LON: ATMA) is a financial services institution founded by Bob Diamond and listed on the London Stock Exchange. With a presence in seven sub-Saharan countries, Atlas Mara aims to be a positive disruptive force in the markets in which we operate by leveraging technology to provide innovative and differentiated product offerings, deliver excellent customer service and accelerate financial inclusion. For more information, visit www.atlasmara.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Atlas Mara

ReleaseID: 557728

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Venator Materials PLC To Contact The Firm

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Venator Materials PLC (“Venator” or the “Company”) (NYSE:VNTR) of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Venator stock or options between August 2, 2017 and October 29, 2018, inclusive (the “Class Period”), and/or pursuant to the Company’s initial public offering conducted on or around August 3, 2017 (the “IPO”), and/or pursuant to the Company’s secondary public offering conducted on or around December 4, 2017 (the “SPO,” and together with the IPO, the “Offerings”) and would like to discuss your legal rights, click here: www.faruqilaw.com/VNTR. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Venator securities between August 2, 2017 and October 29,

2018, and/or pursuant to the Company’s initial public offering conducted on or around August 3, 2017, and/or pursuant to the Company’s secondary public offering conducted on or around December 4, 2017. The case, City Of Miami General Employees’ & Sanitation Employees’ Retirement Trust v. Venator Materials PLC, Docket No. 1:19-cv-07182 was filed on July 31, 2019 and has been assigned to District Judge Edgardo Ramos.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by misrepresenting the true extent of the fire damage to Venator’s Pori facility, the cost to rehabilitate the facility, and the impact on Venator’s business and operations.

Specifically, the Company assured investors that the Pori facility would be rebuilt with insurance proceeds within its policy limits. Throughout the Class Period, Venator and its executives continued to assure investors that the rebuild of the Pori facility was on track and that the Company would be able to fully recoup the production capacity lost in the fire. As a result of these misrepresentations, Venator shares traded at artificially inflated prices throughout the Class Period.

On July 31, 2018, Venator revealed that the fire damage at the Pori facility was far more extensive than Defendants had previously represented to investors. Venator announced that the cost to repair the facility had climbed to more than $375 million above the insurance policy limits, more than double the amount disclosed to investors just two months after the IPO.

On this news, Venator’s stock price fell from $15.35 on July 30, 2018 to $14.62 on July 31, 2018-a $0.73 or a 4.80% drop.

Then, on September 12, 2018, Venator announced that it was abandoning the Pori facility altogether, despite the Company’s previous assurances that the site would be repaired and restored back to its full operating capacity. The Company also revealed that the facility was still only operating at 20% capacity and thus had not increased production by any meaningful amount during the thirteen months since the IPO. During an investor conference call held later that same day, Venator’s Chief Executive Officer (“CEO”), Defendant Simon Turner, admitted that the Company had misrepresented the true extent of the fire damage. When asked by an analyst whether Venator had provided a “misestimate of the initial amount of damage from the fire” and whether “the actual work that needed to be done was missed,” CEO Turner agreed that “it was a combination of factors, both of which, you’ve mentioned already.”

On this news, Venator’s stock price fell from $11.35 on September 11, 2018 to $10.81 on September 12, 2018-a $0.54 or a 4.76% drop.

Finally, on October 30, 2018, Venator announced that, in addition to the over $500 million in costs and lost business associated with the Pori fire incurred to date, the Company incurred a restructuring expense of approximately $415 million and would incur additional “charges of $220 million through the end of 2024” related to the Pori site.

As a result of these disclosures, the Company’s stock price declined from $8.00 per share to $6.47 per share, or more than 19%.

On this news, Venator’s stock price fell from $8.00 on October 29, 2018 to $6.47 on October 30, 2018-a $1.53 or a 19.13% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Venator’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 557596

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Cardinal Health, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE:CAH) of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Cardinal Health stock or options between March 2, 2015 and May 2, 2018 and would like to discuss your legal rights, click here: www.faruqilaw.com/CAH. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Southern District of Ohio on behalf of all those who purchased Cardinal Health common stock between March 2, 2015 and May 2, 2018 (the “Class Period”). The case, Louisiana Sheriffs Pension & Relief Fund v. Cardinal Health, Inc. et al., No. 19-cv-03347 was filed on August 1, 2019, and has been assigned to Judge Edmund A. Sargus.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by misleading investors by stating that Cordis Corp. (“Cordis”), a manufacturer of medical devices that Cardinal purchased from Johnson & Johnson in March of 2015, would benefit from Cardinal’s advanced inventory management and supply chain information technology solutions.

On August 2, 2017, Cardinal reported weak earnings for its fourth quarter and fiscal year 2017 and lowered its earnings guidance for fiscal year 2018 due in part to “higher-than-planned write-offs for excess inventory” at Cordis.

On this news, the Company’s stock price fell from $77.33 per share on August 1, 2017 to $70.99 per share on August 2, 2017, a $6.34 or 8.20% drop.

Then, on May 3, 2018, Cardinal announced disappointing results for its third quarter fiscal year 2018 and cut its fiscal year 2018 earnings guidance. The Company explained that the “biggest variable driving these results” was the “disappointing performance” of the Cordis business. Contrary to the Company’s prior statements that it had visibility into Cordis’s inventory and that the Company properly reserved for obsolete inventory, the Company revealed that after launching a new global supply chain IT platform over the last quarter at Cordis, it discovered millions of dollars of unsellable and expired heart stents and catheters stationed overseas that had to be written off.

On this news, the Company’s stock price fell from $64.65 per share on May 2, 2018 to $50.80 per share on May 3, 2018, a $13.85 or 21.42% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Cardinal Health’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 557595

Vaccine Adjuvants Market Global Size 2019, Industry Analysis by Growth, Demand, Share, Trends, Competitive Landscape, Top Companies, Regional Forecast to 2023

Vaccine Adjuvants Market Information: By Type (Pathogen Components, Particulate Adjuvants, others), By Route of Administration (Oral, Intramuscular, Subcutaneous, and Intradermal), and By End Users (Pediatric, Adult) – Global Forecast Till 2023

Pune, India – August 28, 2019 /MarketersMedia/

Market Overview:

Vaccine adjuvant is formulated as a component of vaccine which enhances the effectiveness of vaccine and its ability to protect against infections. Adjuvant aids in activating the immune system which in turn provides the body with long-term protective immunity against various types of infections and diseases. Market Research Future (MRFR) has recently published a report asserting that the global vaccine adjuvants market is marked to expand at a noteworthy CAGR of 10.1% during the forecast period of 2017-2023.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/1098

Market Drivers and Restraints:

Rise in prevalence of various diseases that directly attack the immune system of human beings has led to the increased demand for vaccines all over the world., which in turn is propelling the growth of the global vaccine adjuvants market. The ability of adjuvants to enhance the effectiveness of vaccines and increased research and development for introducing high-quality vaccines are some other factors that are fueling the expansion of the global vaccine adjuvants market. However, low penetration of advanced healthcare solutions, low research and development expenditure in underdeveloped regions and lack of awareness in these regions are likely to restrain the growth of the global vaccine adjuvants market during the assessment period.

Market Segmentation:

The global vaccine adjuvants market has been are segmented on the basis of types, routes of administration, and end users. Based on types, the vaccine adjuvants market has been segmented into pathogen components, particulate adjuvants, and others. The particulate adjuvants segment is dominating the global vaccine adjuvants market owing to the presence of large variety of products and its greater efficiency in the treatment of diseases. Based on routes of administration, the vaccine adjuvants market has been segmented into oral, intramuscular, subcutaneous, and intradermal. The intramuscular segment commanded for the major share in the global vaccine adjuvants market as this route of administration of vaccines provide better immune specificity. Based on end users, the vaccine adjuvants market has been segmented into pediatric, adult.

Regional Analysis:

Geographically, the global vaccine adjuvants market has been segmented into four major regions such as the America, Asia Pacific, Europe, and the Middle East and Africa. The Americas command for the major share in the global vaccine adjuvants market owing to the high demand for vaccines, increased healthcare expenditure and increased utilization of advanced technology for the development of advanced medications in the well-developed healthcare infrastructure in this region. The Europe region commands for the second largest share in the global vaccine adjuvants market owing to the research and development activities carried out in the biotechnological and pharmaceutical industries for introducing highly effective vaccines to tackle various diseases and increased healthcare expenditure by the population of this region. The Asia Pacific region is projecting fastest growth in the global vaccine adjuvants market owing to the increased prevalence of contagious diseases and improvement in the healthcare sector of emerging economies like India and China in this region. Lack of awareness and low penetration of primary healthcare solutions are leading to the slow growth of the vaccine adjuvants market in the Middle East and Africa region.

Competitive Analysis:

With the help of advanced technology, the players in the global vaccine adjuvants market are focusing on business expansion by developing advanced products for creating highly effective vaccines. Strategic mergers and acquisitions are aiding these players to sustain the competitive environment of the global vaccine adjuvants market.

The leading players profiled by MRFR that are operating in the global vaccine adjuvants market are VaxLiant LLC.(the U.S), Vaxine Pty Ltd (Australia), Aphios Corporation (the U.S), Viscogel AB (Sweden), Adjuvatis (France), Sergeant Adjuvants (the U.S), Sigma-Aldrich Co. LLC.(India), CureVac AG (Germany), Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (the U.S), Novavax, Inc.(the U.S), SPI Pharma, Inc.(the U.S), Invivogen (the U.S), Avanti Polar Lipids, Inc. (the U.S), MPV Technologies (the U.S), and OZ Biosciences (France).

Table Of Contents

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Scope Of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4 Market Dynamics

4.1 Drivers

4.2 Restraints

5 Market Factor Analysis

…Continued

Get access to full summary @ https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098

Source URL: https://marketersmedia.com/vaccine-adjuvants-market-global-size-2019-industry-analysis-by-growth-demand-share-trends-competitive-landscape-top-companies-regional-forecast-to-2023/88913139

Source: MarketersMedia

Release ID: 88913139

Exoskeleton Market 2019 – Asia Pacific to be A Key Revenue Contributor

Characterized by technological innovations, exoskeleton market strives to bring about a transformation in rehabilitation devices for consumer comfort

Selbyville, United States – August 28, 2019 /MarketersMedia/

Asia Pacific has been proclaimed to emerge as the next lucrative growth ground for exoskeleton market, given the robust demand for wearables in the region. The growing geriatric population in the continent, vulnerable to strokes and mobility issues, would demand the deployment of rehabilitation therapy procedures. This would subsequently necessitate the requirement of advanced exoskeletons designed to help patients with gait training and the like, thereby providing a boost to APAC exoskeleton market share.

Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/1946

Most of the companies headquartered in the Asia Pacific have reportedly been striving toward developing innovative products that would be deployed across the military and healthcare sectors. For instance, the South Korean automotive giant, Hyundai Motor Company, recently made it to the headlines for having developed an exoskeleton called the H-MEX (Hyundai Medical Exoskeleton), especially designed for paraplegics. Having debuted at the CES 2017, H-MEX is the firm’s first exoskeleton and is manufactured to allow patients paralyzed from below the waist to regain balance, in addition to improving the blood circulation among patients.

Characterized by technological innovations, exoskeleton market strives to bring about a transformation in rehabilitation devices for consumer comfort. In yet another breakthrough, Lowe’s companies Incorporation, a key player across the retail industry, and Virginia Tech, an educational institute & university based in the U.S., have built a soft & light exosuit to help the employees working in Lowe’s retail stores to easily lift and move heavy products across the store.

The Wyss-ReWalk partnership inked in Q3 2017 sent out waves of anticipation across exoskeleton industry, based on the premise of the fact that both the organizations have been striving toward helping people with physical impairments. Elaborating further, ReWalk recently made it to the headlines for working on an exoskeleton designed to enable stroke affected patients regain their mobility. In consequence, the firm signed a partnership with the Wyss Institute, Harvard, renowned for specializing in the development of innovative technology powered by biological design principles.

Browse key industry insights spread across 350 pages with 406 market data tables & 15 figures & charts from the report, “Exoskeleton Market” in detail along with the table of contents @ https://www.gminsights.com/industry-analysis/exoskeleton-market

Exoskeleton market find wide applications across healthcare, industrial, and military sectors. The introduction of new technologies across the healthcare sector to ensure the safety coupled with the allocation of funds for healthcare will spur the product penetration. Healthcare applications are expected to emerge as the dominant application segment by 2026, owing to the rising demand for rehabilitation spurred by disorders such as Parkinson’s disease, spinal cord injuries, and other gait disorders. Not to mention, exoskeletons offer numerous benefits to healthcare providers, reducing the burden that therapists endure during training and therapy.

Major corporations such as ReWalk Robotics, Lockheed Martin, REX Bionics, Panasonic Corporation, and Cyberdyne Incorporation have made remarkable contributions toward augmenting exoskeleton market size in recent years. The recent breakthroughs witnessed across the business landscape indeed validate the claims put forward by market analysts, who state that exoskeleton industry would be worth more than USD 3.5 billion by 2026.

Some Points From Table Of Content: –

Chapter 6 Exoskeleton Market, By Technology
6.1 Exoskeleton industry share by technology, 2018 & 2026
6.2 Passive
6.2.1 Passive exoskeleton industry estimates and forecast, 2014 – 2026, (Units) (USD Million)
6.2.2 Passive exoskeleton industry estimates & forecast, by region, 2014-2026 (Units) (USD Million)
6.3 Semi-passive
6.3.1 Semi-passive exoskeleton industry estimates and forecast, 2014 – 2026, (Units) (USD Million)
6.3.2 Semi-passive exoskeleton industry estimates & forecast, by region, 2014-2026 (Units) (USD Million)
6.4 Active
6.4.1 Active exoskeleton industry estimates and forecast, 2014 – 2026, (Units) (USD Million)
6.4.2 Active exoskeleton industry estimates & forecast, by region, 2014-2026 (Units) (USD Million)

Browse complete Table of Contents (ToC) of this research report @ https://www.gminsights.com/toc/detail/exoskeleton-market

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Global Market Insights, Inc.
Address: Global Market Insights, Inc., 4 North Main Street,
Phone: 3028467766
Website: https://www.gminsights.com/pressrelease/exoskeleton-market

Source URL: https://marketersmedia.com/exoskeleton-market-2019-asia-pacific-to-be-a-key-revenue-contributor/88913122

Source: MarketersMedia

Release ID: 88913122

Asia Pacific Endpoint Security Market Share to be Worth at $1bn by 2024

Graphical Research has reported the addition of the “Endpoint Security Market: Asia Pacific Industry Analysis and Opportunity Assessment 2019 – 2024″ report to their offering.

India – August 28, 2019 /MarketersMedia/

According to the Graphical Research new growth forecast report titled “Asia Pacific Endpoint Security Market Size By Component (Service, Software), By Deployment Model, By Application, Regional Outlook, Industry Size, Share, Growth Trends & Forecast, 2017 – 2024”, estimated to exceed USD 1 billion by 2024

Request for a sample of this report @ https://www.graphicalresearch.com/request/1158/sample

Some of the key vendors in the Asia Pacific endpoint security market include Symantec, Webroot Cisco, ESET, McAfee, Kaspersky Lab, VIPRE, Trend Micro, Sophos, Microsoft, Ahnlab, Comodo, Panda Security, IBM, and F-Secure.

The Asia Pacific endpoint security market is growing due to the high rate of cyber-crimes and the extensive use of internet. India was ranked among the top five countries to be affected by cybercrimes in 2017, according to the Internet Security Threat Report (ISTR) by an online security firm Symantec. According to the ISTR by Symantec, Australia ranked second for having the highest proportion of malicious email-borne attack links in 2017. The rise in cyberattacks on government institutions and corporate networks has resulted in the adoption of firewall & encryption technologies mandatory with features such as application identification and control. The growing concerns for data breaches and the use of cloud computing platforms will help to stimulate the spending on the cloud firewall market.

Make an Inquiry for purchasing this Report @ https://www.graphicalresearch.com/request/1158/inquiry-before-buying

The healthcare sector is expected to hold a market share of over 16% in 2024 due to the rising incidents of cyberattacks on healthcare networks. The rising cyberattacks in the healthcare industry due to internet-connected devices will increase the need to adopt advanced endpoint security solutions, such as intrusion prevention, anti-virus, and endpoint application control, to minimize the network vulnerabilities.

The Japan endpoint security market is projected to register an accelerated growth of over 8% between 2017 and 2024. Global cybersecurity companies are expanding their presence in Japan, strengthening the country’s cybersecurity infrastructure and offering advanced cybersecurity products to customers. In August 2016, Cylance, an American cybersecurity company, opened its new office in Japan to support the regional customers as well as OEMs. The Japanese government is currently working on various policies and training initiatives to improve the country’s cyber rating. The Ministry of Internal Affairs and Communications (MIC) launched the IoT Cybersecurity Action Program in January 2017, which accelerates the government’s efforts to build a skilled cyber workforce and establish a training center.

Browse Table of Contents @ https://www.graphicalresearch.com/table-of-content/1158/asia-pacific-endpoint-security-market

Segments we cover:

Asia Pacific Endpoint Security Market Growth, By Component
Software
Firewall
Intrusion Prevention
Antivirus/Anti-Malware
Endpoint Application Control
Encryption Technologies
Mobile Device Security
Service
Training & Consulting
Maintenance & Updates
Managed Service

Asia Pacific Endpoint Security Market Trends, By Deployment Model
On-premise
Cloud

Asia Pacific Endpoint Security Market Size, By Application
BFSI
Telecom & IT
Retail
Healthcare
Government & Public Sector
Education
Transportation

Browse key industry insights from this Report @ https://www.graphicalresearch.com/industry-insights/1158/asia-pacific-endpoint-security-market

Related Reports:

North America Endpoint Security Market : https://www.graphicalresearch.com/industry-insights/1161/north-america-endpoint-security-market

LAMEA Endpoint Security Market : https://www.graphicalresearch.com/industry-insights/1160/lamea-endpoint-security-market

Europe Endpoint Security Market : https://www.graphicalresearch.com/industry-insights/1159/europe-endpoint-security-market

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

Contact Info:
Name: Parikhit B.
Email: Send Email
Organization: Graphical Research
Website: https://www.graphicalresearch.com/industry-insights/1158/asia-pacific-endpoint-security-market

Source URL: https://marketersmedia.com/asia-pacific-endpoint-security-market-share-to-be-worth-at-1bn-by-2024/88913128

Source: MarketersMedia

Release ID: 88913128

DEADLINE ALERT – Diebold Nixdorf, Incorporated (DBD) – Bronstein, Gewirtz & Grossman, LLC Reminds Class Action and Lead Deadline: September 3, 2019

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Diebold Nixdorf, Incorporated (“Diebold” or the “Company”) (NYSE:DBD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Diebold securities from May 4, 2017 and July 4, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/dbd.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing delays in systems rollouts as well as a longer customer decision-making process and order-to-revenue conversion cycle; (2) the foregoing issues were negatively impacting the Company’s services business and operations; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

On July 5, 2017, Diebold issued a press release titled “Diebold Nixdorf Adjusts 2017 Financial Outlook” (the “July 2017 Press Release”). The July 2017 Press Release disclosed that the Company expected a wider net loss than indicated in its prior guidance for fiscal 2017, from a range of $50 to $75 million to a range of $110 to $125 million net loss. Diebold attributed the lowered expectations to a delay in systems rollouts as well as a longer customer decision-making process and order-to-revenue conversion cycle. Following this news, Diebold’s stock price fell $6.40 per share, or nearly 23%, to close at $21.60 per share on July 5, 2017.

If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/dbd or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Diebold you have until September 3, 2019 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 557333

The LCG Energy Company: A Licensed Energy Contractor and Provider with Over 10 Years of Market Experience

WÜRSELEN, GERMANY / ACCESSWIRE / August 28, 2019 / 95% of all companies on the blockchain market attempting to raise funds through an ICO / STO or an IEO are start ups. With this number in mind, one cannot be surprised by the abnormally high rates of failed projects on the market – over 90% of all ICOs disappear within the year of their launch.

Companies that have existed for at least 3 years on the market have proven to be much more successful with their blockchain initiatives compared to newly founded startups.
These companies not only have obtained valuable market insight on their respective markets, but have also built a strong customer base and have valuable resources – financial, human capital to partner networks and legal certifications.

An experienced company founded in 2009, with a solid base of 50.000 customers and a vast network of more than 1100 direct partners and 10.000 external providers is about to become the first electricity provider and energy contractor to adopt blockchain technology. We are talking about LCG Energy, a German based company with subsidiaries across 5 countries.

About LCG Energy

LCG Energy is a licensed energy supplier, reseller and contractor with over 10 years of experience. Founded in 2009, the company has established itself as one of the few supply companies on the German and Austrian energy markets, an achievement that requires a lot of expertise and resources considering the extremely high entry barriers from a financial, technical and regulatory standpoint. Building the necessary technical infrastructure in order to satisfy the energy demands of over 50.000 customers requires substantial capital investments and years of preparation and LCG has done it.

The history of LCG Energy is as impressive as its achievements in the past several years.The company has been established and funded completely with private funds and has managed to score excellent bottom-line financial performance every year. With a revenue of 20M EUR in 2018, and a projected revenue of 90M EUR in 2019 thanks to the closing of several important partnerships in the industry,

In 2015, LCG Energy has been certified by the German and Austrian Federal Network Agencies for Electricity, Gas, Telecommunications, Post and Railway, a major milestone for the company positioning it as one of the few independent electricity providers in the D-A-CH region.

LCG Energy has established its purpose to provide small to medium-sized businesses and individuals with better energy prices and help them optimize their energy consumption. One of the ways they have managed to achieve that is due to their expertise in trading energy on the open market, resulting in up to 20% below average prices for the end customer compared to traditional electricity providers.

As an energy contractor, the company is specializing in the optimization of energy consumption for individual households and businesses with the help of Smart Meters. Smart Meters are innovative devices that function as the traditional electrical meters at home but are able to transmit data virtually to a central data point. The advantages of Smart Meters are numerous – first, there is no need for company representative to do manual readings, which is resource intensive for the company and results in higher prices for the consumer. Second, Smart Meters allow for energy usage data collection and aggregation with a wide access to it through mobile devices and computers. What is more, collecting and analyzing data digitally enables valuable insight about the power consumption of each individual customer, allowing for tailored suggestions and strategies such as:

Elimination of power consumption by standby devices

Elimination of so called “creeping current” that not only increases energy consumption but also potentially creates the danger of malfunction which could lead to severe consequences for the property and the well-being of its inhabitants or workers.

Spotting inefficient processes within electrical devices and machines

The potential savings from Smart Meters can reach 20 to 30%, resulting in average savings for household with a 4000 kWh consumption amounting to 200 EUR per year or 1355 EUR for a medium-sized business with a 50000 kWh yearly consumption.

The LCG Energy project

Drawing on their strong foundation and market experience, the LCG Energy company has been researching the possible use cases of blockchain technology in the energy industry for the past two years. As a result, the first plans for the LCG Energy ecosystem emerged approximately a year ago and the first prototype of the LCG platform was born.

The purpose of the ecosystem will be to empower the end consumer and allow him to benefit from the increased transparency, security and improved transactions that distributed ledgers can offer. The LCG platform will enable direct customers of LCG Energy to pay for their electricity needs with the LCG tokens. Users who do not have access to the direct services of the company will be able to obtain energy related services and products from the supplier and partner network of LCG Energy. Furthermore, investment opportunities in renewable energy projects that have been strictly evaluated by LCG Energy will be made available on the platform.

Last but not least, there is much more that blockchain can offer to the energy industry from a technical standpoint when integrated to the Smart Meters that LCG Energy is already installing.

LCG Energy is one of the few companies on the blockchain market that has existed for more than 10 years and is here to stay. With their vast market expertise and an established technical infrastructure, the company is equipped with the knowledge and resources to change the traditional monopolistic structures on the market that hurt the end consumer.

Company Name: LCG Energy
Contact Person: Dipl. -Kfm Michael Opitz
Email: info@lcg-group.de
Country: Germany
Website: https://lcg-group.de

SOURCE: LCG Energy

ReleaseID: 557473